BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Terrault NA, Stravitz RT, Lok AS, Everson GT, Brown RS Jr, Kulik LM, Olthoff KM, Saab S, Adeyi O, Argo CK, Everhart JE, Rodrigo del R; A2ALL Study Group. Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study. Hepatology 2014;59:1311-9. [PMID: 24677192 DOI: 10.1002/hep.26920] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Tran L, Humar A. Current status of adult liver transplantation: utilization of living donor versus deceased donor graft. Curr Opin Organ Transplant 2021;26:133-8. [PMID: 33595979 DOI: 10.1097/MOT.0000000000000849] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
2 Tang W, Qiu JG, Cai Y, Cheng L, Du CY. Increased Surgical Complications but Improved Overall Survival with Adult Living Donor Compared to Deceased Donor Liver Transplantation: A Systematic Review and Meta-Analysis. Biomed Res Int 2020;2020:1320830. [PMID: 32908865 DOI: 10.1155/2020/1320830] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
3 Abu-gazala S, Olthoff KM. Status of Adult Living Donor Liver Transplantation in the United States. Gastroenterology Clinics of North America 2018;47:297-311. [DOI: 10.1016/j.gtc.2018.01.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]
4 Ganesh S, Almazroo OA, Tevar A, Humar A, Venkataramanan R. Drug Metabolism, Drug Interactions, and Drug-Induced Liver Injury in Living Donor Liver Transplant Patients. Clin Liver Dis 2017;21:181-96. [PMID: 27842771 DOI: 10.1016/j.cld.2016.08.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
5 Clouston AD, Hübscher SG. Transplantation Pathology. Macsween's Pathology of the Liver 2018. [DOI: 10.1016/b978-0-7020-6697-9.00014-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Saxena V, Terrault NA. Recurrent Primary Disease After Liver Transplantation. Zakim and Boyer's Hepatology 2018. [DOI: 10.1016/b978-0-323-37591-7.00053-7] [Reference Citation Analysis]
7 Kim JM, Lee KW, Song GW, Jung BH, Lee HW, Yi NJ, Kwon CHD, Hwang S, Suh KS, Joh JW, Lee SK, Lee SG. Increased survival in hepatitis c patients who underwent living donor liver transplant: a case-control study with propensity score matching. Ann Surg Treat Res 2017;93:293-9. [PMID: 29250507 DOI: 10.4174/astr.2017.93.6.293] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Ali MA, Elshobari MM, Salah T, Kandeel AR, Sultan AM, Elghawalby AN, Shehta A, Elsayed U, Fathy O, Yassen A, Wahab MA. Impact of donor-recipient genetic relationship on outcome of living donor liver transplantation. Liver Transpl 2017;23:43-9. [PMID: 27516392 DOI: 10.1002/lt.24599] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
9 Fisher RA. Living donor liver transplantation: eliminating the wait for death in end-stage liver disease? Nat Rev Gastroenterol Hepatol. 2017;14:373-382. [PMID: 28196987 DOI: 10.1038/nrgastro.2017.2] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 7.4] [Reference Citation Analysis]
10 Baker TB, Caicedo JC. Living-donor liver transplantation. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set 2017. [DOI: 10.1016/b978-0-323-34062-5.00117-5] [Reference Citation Analysis]
11 Rubín A, Berenguer M. HCV Recurrence: Predictors and Outcomes After Liver Transplantation. Disease Recurrence After Liver Transplantation 2016. [DOI: 10.1007/978-1-4939-2947-4_3] [Reference Citation Analysis]
12 Chokechanachaisakul A, Baker T. Living Donor Liver Transplantation (LDLT). Curr Surg Rep 2015;3. [DOI: 10.1007/s40137-015-0119-9] [Reference Citation Analysis]
13 Olthoff KM, Smith AR, Abecassis M, Baker T, Emond JC, Berg CL, Beil CA, Burton JR Jr, Fisher RA, Freise CE, Gillespie BW, Grant DR, Humar A, Kam I, Merion RM, Pomfret EA, Samstein B, Shaked A. Defining long-term outcomes with living donor liver transplantation in North America. Ann Surg 2015;262:465-75; discussion 473-5. [PMID: 26258315 DOI: 10.1097/SLA.0000000000001383] [Cited by in Crossref: 94] [Cited by in F6Publishing: 96] [Article Influence: 13.4] [Reference Citation Analysis]
14 Barsa JE, Branch AD, Schiano TD. A pleasant dilemma to have: to treat the HCV patient on the waiting list or to treat post-liver transplantation? Clin Transplant 2015;29:859-65. [DOI: 10.1111/ctr.12596] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
15 Mitchell O, Gurakar A. Management of Hepatitis C Post-liver Transplantation: a Comprehensive Review. J Clin Transl Hepatol. 2015;3:140-148. [PMID: 26357641 DOI: 10.14218/jcth.2015.00005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
16 Filipec Kanizaj T, Kunac N. Hepatitis C: New challenges in liver transplantation. World J Gastroenterol 2015; 21(19): 5768-5777 [PMID: 26019441 DOI: 10.3748/wjg.v21.i19.5768] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
17 Monaghan KG, Gonzalez HC, Levin AM, Abouljoud MS, Gordon SC. Post-transplant course of hepatitis C after living donor liver transplantation in association with polymorphisms near IFNL3. J Interferon Cytokine Res 2015;35:313-6. [PMID: 25343304 DOI: 10.1089/jir.2014.0111] [Reference Citation Analysis]